DTLVX
Price
$22.83
Change
+$0.12 (+0.53%)
Updated
Jul 3 closing price
Net Assets
168.61M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

DTLVX vs VVIAX

Header iconDTLVX vs VVIAX Comparison
Open Charts DTLVX vs VVIAXBanner chart's image
Wilshire Large Company Value Invmt
Price$22.83
Change+$0.12 (+0.53%)
VolumeN/A
Net Assets168.61M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
DTLVX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DTLVX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTLVX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. DTLVX (169M). VVIAX pays higher dividends than DTLVX: VVIAX (2.18) vs DTLVX (0.71). DTLVX was incepted earlier than VVIAX: DTLVX (33 years) vs VVIAX (25 years). DTLVX (1.31) is less costly to investors than VVIAX (0.05). DTLVX is a more actively managed with annual turnover of: 38.00 vs. VVIAX (9.00). DTLVX has a lower initial minimum investment than VVIAX: DTLVX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. DTLVX (6.68). VVIAX return over 5 years is better than : 80.13 vs. DTLVX (47.41).
DTLVXVVIAXDTLVX / VVIAX
Total Expense Ratio1.300.052,600%
Annual Report Gross Expense Ratio1.310.052,620%
Fund Existence33 years25 years-
Gain YTD7.8416.198127%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets169M189B0%
Annual Yield % from dividends0.712.1832%
Returns for 1 year6.6812.0356%
Returns for 3 years23.4235.1767%
Returns for 5 years47.4180.1359%
Returns for 10 years18.60115.6716%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.